Patent and exclusivity status of essential medicines for non-communicable disease
about
Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.Essential medicines are more available than other medicines around the globeAddressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy.Could patents interfere with the development of a cardiovascular polypill?Which patent and where? Why international patent transparency by companies is needed for medicines.
P2860
Patent and exclusivity status of essential medicines for non-communicable disease
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Patent and exclusivity status of essential medicines for non-communicable disease
@ast
Patent and exclusivity status of essential medicines for non-communicable disease
@en
Patent and exclusivity status of essential medicines for non-communicable disease
@nl
type
label
Patent and exclusivity status of essential medicines for non-communicable disease
@ast
Patent and exclusivity status of essential medicines for non-communicable disease
@en
Patent and exclusivity status of essential medicines for non-communicable disease
@nl
prefLabel
Patent and exclusivity status of essential medicines for non-communicable disease
@ast
Patent and exclusivity status of essential medicines for non-communicable disease
@en
Patent and exclusivity status of essential medicines for non-communicable disease
@nl
P2860
P3181
P1433
P1476
Patent and exclusivity status of essential medicines for non-communicable disease
@en
P2093
Bryan A Liang
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0051022
P407
P577
2012-01-01T00:00:00Z